Equities

Argent Biopharma Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Argent Biopharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.058
  • Today's Change0.001 / 1.75%
  • Shares traded44.98k
  • 1 Year change-53.60%
  • Beta0.1985
Data delayed at least 20 minutes, as of Feb 16 2026 23:11 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2025202520242023
REVENUE AND GROSS PROFIT
Total revenue0.180.893.39
OPERATING EXPENSES
Cost of revenue total1.734.636.39
Selling, general and admin. expenses, total10118.24
Depreciation/amortization0.791.290.75
Unusual expense(income)2.39(0.09)4.53
Other operating expenses, total(0.55)(0.14)0.22
Total operating expense181923
Operating income(18)(18)(20)
Other, net00.060.22
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes(18)(18)(21)
Provision for income taxes0--0.00
Net income after taxes(18)(18)(21)
Minority interest00.020.31
Net income before extra. Items(18)(18)(21)
Total extraordinary items------
Net income(18)(18)(21)
Inc.avail. to common excl. extra. Items(18)(18)(21)
Inc.avail. to common incl. extra. Items(18)(18)(21)
EPS RECONCILIATION
Basic/primary weighted average shares57372.93
Basic/primary eps excl. extra items(0.31)(0.47)(7.1)
Basic/primary eps incl. extra items(0.31)(0.47)(7.1)
Dilution adjustment------
Diluted weighted average shares57372.93
Diluted eps excl. extra items(0.31)(0.47)(7.1)
Diluted eps incl. extra items(0.31)(0.47)(7.1)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.040.040.17
SUPPLEMENTAL INCOME
Depreciation, supplemental0.791.290.75
Total special items2.39(0.09)4.53
NORMALISED INCOME
Normalized income before taxes(15)(18)(17)
Effect of special items on income taxes001.59
Income tax excluding impact of special items001.59
Normalized income after tax(15)(18)(18)
Normalized income avail. to common(15)(18)(18)
Basic normalized EPS(0.27)(0.48)(6.1)
Diluted normalized EPS(0.27)(0.48)(6.1)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.